366 related articles for article (PubMed ID: 28538082)
1. Risk Factors Associated With Failure to Reach Minimal Clinically Important Difference in Patient-reported Outcomes Following Minimally Invasive Transforaminal Lumbar Interbody Fusion for Spondylolisthesis.
Hijji FY; Narain AS; Bohl DD; Yom KH; Kudaravalli KT; Lopez GD; Singh K
Clin Spine Surg; 2018 Feb; 31(1):E92-E97. PubMed ID: 28538082
[TBL] [Abstract][Full Text] [Related]
2. Revisions for screw malposition and clinical outcomes after robot-guided lumbar fusion for spondylolisthesis.
Schröder ML; Staartjes VE
Neurosurg Focus; 2017 May; 42(5):E12. PubMed ID: 28463610
[TBL] [Abstract][Full Text] [Related]
3. Do measures of surgical effectiveness at 1 year after lumbar spine surgery accurately predict 2-year outcomes?
Adogwa O; Elsamadicy AA; Han JL; Cheng J; Karikari I; Bagley CA
J Neurosurg Spine; 2016 Dec; 25(6):689-696. PubMed ID: 26722957
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Preoperative Symptom Duration on Postoperative Outcomes After Minimally Invasive Transforaminal Lumbar Interbody Fusion.
Yoo JS; Patel DS; Hrynewycz NM; Brundage TS; Mogilevsky FA; Singh K
Clin Spine Surg; 2020 Jul; 33(6):E263-E268. PubMed ID: 31503049
[TBL] [Abstract][Full Text] [Related]
5. Utility of minimum clinically important difference in assessing pain, disability, and health state after transforaminal lumbar interbody fusion for degenerative lumbar spondylolisthesis.
Parker SL; Adogwa O; Paul AR; Anderson WN; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 May; 14(5):598-604. PubMed ID: 21332281
[TBL] [Abstract][Full Text] [Related]
6. Assessment of radiographic and clinical outcomes of an articulating expandable interbody cage in minimally invasive transforaminal lumbar interbody fusion for spondylolisthesis.
Massie LW; Zakaria HM; Schultz LR; Basheer A; Buraimoh MA; Chang V
Neurosurg Focus; 2018 Jan; 44(1):E8. PubMed ID: 29290133
[TBL] [Abstract][Full Text] [Related]
7. Impact of local steroid application in a minimally invasive transforaminal lumbar interbody fusion: results of a prospective, randomized, single-blind trial.
Haws BE; Khechen B; Patel DV; Bawa MS; Ahn J; Bohl DD; Mayo BC; Massel DH; Guntin JA; Cardinal KL; Singh K
J Neurosurg Spine; 2018 Nov; 30(2):222-227. PubMed ID: 30497132
[TBL] [Abstract][Full Text] [Related]
8. A comparison of minimally invasive transforaminal lumbar interbody fusion and decompression alone for degenerative lumbar spondylolisthesis.
Chan AK; Bisson EF; Bydon M; Glassman SD; Foley KT; Potts EA; Shaffrey CI; Shaffrey ME; Coric D; Knightly JJ; Park P; Wang MY; Fu KM; Slotkin JR; Asher AL; Virk MS; Kerezoudis P; Alvi MA; Guan J; Haid RW; Mummaneni PV
Neurosurg Focus; 2019 May; 46(5):E13. PubMed ID: 31042655
[TBL] [Abstract][Full Text] [Related]
9. Single-level Minimally Invasive Transforaminal Lumbar Interbody Fusion Versus Anterior Lumbar Interbody Fusion for the Surgical Treatment of Isthmic Spondylolisthesis.
Patel MR; Jacob KC; Pawlowski H; Prabhu MC; Vanjani NN; Singh K
J Am Acad Orthop Surg; 2022 Nov; 30(21):e1382-e1390. PubMed ID: 36264190
[TBL] [Abstract][Full Text] [Related]
10. [Clinical outcomes of single-level lumbar spondylolisthesis by minimally invasive transforaminal lumbar interbody fusion with bilateral tubular channels].
Zeng ZL; Jia L; Yu Y; Xu W; Hu X; Zhan XH; Jia YW; Wang JJ; Cheng LM
Zhonghua Wai Ke Za Zhi; 2017 Apr; 55(4):279-284. PubMed ID: 28355766
[No Abstract] [Full Text] [Related]
11. Minimally invasive versus open fusion for Grade I degenerative lumbar spondylolisthesis: analysis of the Quality Outcomes Database.
Mummaneni PV; Bisson EF; Kerezoudis P; Glassman S; Foley K; Slotkin JR; Potts E; Shaffrey M; Shaffrey CI; Coric D; Knightly J; Park P; Fu KM; Devin CJ; Chotai S; Chan AK; Virk M; Asher AL; Bydon M
Neurosurg Focus; 2017 Aug; 43(2):E11. PubMed ID: 28760035
[TBL] [Abstract][Full Text] [Related]
12. Does Gender Influence Postoperative Outcomes in Minimally Invasive Transforaminal Lumbar Interbody Fusion?
Khechen B; Haws BE; Patel DV; Cardinal KL; Guntin JA; Singh K
Clin Spine Surg; 2019 Mar; 32(2):E107-E111. PubMed ID: 30407263
[TBL] [Abstract][Full Text] [Related]
13. Defining the minimum clinically important difference for grade I degenerative lumbar spondylolisthesis: insights from the Quality Outcomes Database.
Asher AL; Kerezoudis P; Mummaneni PV; Bisson EF; Glassman SD; Foley KT; Slotkin JR; Potts EA; Shaffrey ME; Shaffrey CI; Coric D; Knightly JJ; Park P; Fu KM; Devin CJ; Archer KR; Chotai S; Chan AK; Virk MS; Bydon M
Neurosurg Focus; 2018 Jan; 44(1):E2. PubMed ID: 29290132
[TBL] [Abstract][Full Text] [Related]
14. Surgical outcomes of patients who fail to reach minimal clinically important differences: comparison of minimally invasive versus open transforaminal lumbar interbody fusion.
Ayling OGS; Rampersaud YR; Dandurand C; Yuan PHS; Ailon T; Dea N; McIntosh G; Christie SD; Abraham E; Bailey CS; Johnson MG; Bouchard J; Weber MH; Paquet J; Finkelstein J; Stratton A; Hall H; Manson N; Thomas K; Fisher CG
J Neurosurg Spine; 2022 Sep; 37(3):376-383. PubMed ID: 35426818
[TBL] [Abstract][Full Text] [Related]
15. A prospective, multi-institutional comparative effectiveness study of lumbar spine surgery in morbidly obese patients: does minimally invasive transforaminal lumbar interbody fusion result in superior outcomes?
Adogwa O; Carr K; Thompson P; Hoang K; Darlington T; Perez E; Fatemi P; Gottfried O; Cheng J; Isaacs RE
World Neurosurg; 2015 May; 83(5):860-6. PubMed ID: 25535070
[TBL] [Abstract][Full Text] [Related]
16. Influence of Preoperative 12-Item Short Form Mental Composite Score on Clinical Outcomes in an Isthmic Spondylolisthesis Population Undergoing Minimally Invasive Transforaminal Lumbar Interbody Fusion.
Patel MR; Jacob KC; Patel SD; Prabhu MC; Vanjani NN; Pawlowski H; Singh K
World Neurosurg; 2022 Feb; 158():e1022-e1030. PubMed ID: 34906755
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of grade I and II degree degenerative lumbar spondylolisthesis with minimally invasive surgery-transforaminal lumbar interbody fusion under Quadrant channel].
Wen J; Yang Y; Zhang H; Liu L; Liu YL; Liu Y; Wang D; Wang ZP
Zhongguo Gu Shang; 2019 Mar; 32(3):199-206. PubMed ID: 30921999
[TBL] [Abstract][Full Text] [Related]
18. Single-Level Minimally Invasive Transforaminal Lumbar Interbody Fusion versus Anterior Lumbar Interbody Fusion with Posterior Instrumentation at L5/S1.
Jacob KC; Patel MR; Ribot MA; Parsons AW; Vanjani NN; Pawlowski H; Prabhu MC; Singh K
World Neurosurg; 2022 Jan; 157():e111-e122. PubMed ID: 34610449
[TBL] [Abstract][Full Text] [Related]
19. Long-term durability of minimal invasive posterior transforaminal lumbar interbody fusion: a clinical and radiographic follow-up.
Rouben D; Casnellie M; Ferguson M
J Spinal Disord Tech; 2011 Jul; 24(5):288-96. PubMed ID: 20975594
[TBL] [Abstract][Full Text] [Related]
20. Does Preoperative Back Pain Impact Patient-reported Outcomes in Patients Undergoing Minimally Invasive Transforaminal Lumbar Interbody Fusion for Isthmic Spondylolisthesis?
Nie JW; Hartman TJ; Zheng E; Oyetayo OO; MacGregor KR; Federico VP; Massel DH; Sayari AJ; Singh K
Clin Spine Surg; 2024 Jun; 37(5):E179-E184. PubMed ID: 38178316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
